Metraipolis › archive › dc_df09c74a4404

Oral delivery of biologics: from barrier-limited formulation to active convective transport — Europe PMC PMID:42158337

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42158337
DOI
10.3389/fddev.2026.1783113
License (as archived)
solo-consultazione
Archived
2026-11-02T17:45:06.429Z
SHA-256 of the archived text
0e0838ed4e1a4b579135069d49627a6b365a87a6e80f950ec168edf99235bccc
Stable URL of this page
https://metraipolis.com/documento/dc_df09c74a4404

How to cite

Oral delivery of biologics: from barrier-limited formulation to active convective transport — Europe PMC PMID:42158337 — Europe PMC (en), https://europepmc.org/article/MED/42158337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df09c74a4404 (Metraipolis archive dc_df09c74a4404, sha256 0e0838ed4e1a4b579135069d49627a6b365a87a6e80f950ec168edf99235bccc)
BibTeX
@misc{dcdf09c74a4404,
  title = {Oral delivery of biologics: from barrier-limited formulation to active convective transport — Europe PMC PMID:42158337},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42158337},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df09c74a4404; sha256 0e0838ed4e1a4b579135069d49627a6b365a87a6e80f950ec168edf99235bccc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42158337. Agents can read the archived copy with the MCP tool read_document.